These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7357520)

  • 1. Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
    Rivera G; Aur RJ; Dahl GV; Pratt CB; Wood A; Avery TL
    Cancer; 1980 Mar; 45(6):1284-8. PubMed ID: 7357520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
    Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
    Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
    Rivera G; Bowman WP; Murphy SB; Dahl GV; Aur RJ; Kalwinsky DK; Wood A; Stagner S; Avery TL
    Med Pediatr Oncol; 1982; 10(5):439-46. PubMed ID: 6958957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
    Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
    Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
    [No Abstract]   [Full Text] [Related]  

  • 6. Etoposide and cytosine arabinoside combination chemotherapy for refractory acute lymphocytic leukemia in childhood.
    Esumi N; Todo S; Arakawa S; Imashuku S
    J Clin Oncol; 1986 Jul; 4(7):1089-93. PubMed ID: 3459812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
    Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
    J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
    Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688
    [No Abstract]   [Full Text] [Related]  

  • 9. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
    Maluf PT; Odone Filho V; Cristofani LM; Britto JL; Almeida MT; Pontes E; Maksoud JG; Manissadjian A
    J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of cytosine arabinoside (NSC-63878) and prednisone (NSC-10023) in refractory childhood lymphoblastic leukemia.
    Nesbit ME; Sonley M; Hammond D
    Med Pediatr Oncol; 1976; 2(1):61-8. PubMed ID: 1064743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
    Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML
    Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
    Bleyer WA; Krivit W; Chard RL; Hammond D
    Cancer Treat Rep; 1979 Jun; 63(6):977-81. PubMed ID: 380803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
    Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
    J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
    Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
    Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy.
    Lay HN; Ekert H; Colebatch JH
    Cancer; 1975 Oct; 36(4):1220-2. PubMed ID: 1058044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
    Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemia.
    Ochs J; Sinkule JA; Danks MK; Look AT; Bowman WP; Rivera G
    J Clin Oncol; 1984 Oct; 2(10):1092-7. PubMed ID: 6593435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
    Smithson WA; Gilchrist GS; Burgert EO
    Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia.
    Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ
    Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.